Skeletal Muscle Wasting and Insulin Resistance Following Surgical Stress
SIRSS
Does Surgical Stress Impair Skeletal Muscle Protein and Carbohydrate Metabolism?
1 other identifier
observational
15
1 country
1
Brief Summary
Background: Skeletal muscle wasting or decrease in muscle mass occurs as a result of alteration in the body's mechanisms to make or break muscle protein. In animal models, the pathway termed as 'ubiquitin-proteasome pathway' (UPP) is primarily responsible for the regulation of skeletal muscle protein loss in wasting conditions and during infection(sepsis). Skeletal muscle wasting is noticed in patients having major surgery due to the inflammatory reaction triggered by special group of proteins called cytokines (inflammatory proteins), resulting in reduced muscle strength, impaired capacity to fight infections, change in bowel function, increased clinical complications and prolonged recovery. Major surgery also leads to decreased sensitivity to hormone known as insulin, resulting in 'diabeteslike'state. We hypothesize that susceptibility of patients undergoing major abdominal surgery, to skeletal muscle wasting and insulin resistance, is determined by stress response to surgery over time, leading to changes in the pathways that make or break muscle protein, namely the Akt/Foxo signalling and UPP. Therefore, the aim of this study is to establish the underlying mechanisms of skeletal muscle wasting and insulin resistance in patients undergoing major abdominal surgery.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for all trials
Started May 2010
Typical duration for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
May 1, 2010
CompletedFirst Submitted
Initial submission to the registry
May 28, 2010
CompletedFirst Posted
Study publicly available on registry
June 2, 2010
CompletedPrimary Completion
Last participant's last visit for primary outcome
May 1, 2013
CompletedStudy Completion
Last participant's last visit for all outcomes
May 1, 2013
CompletedJune 9, 2015
June 1, 2015
3 years
May 28, 2010
June 5, 2015
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
postoperative insulin resistance
First week following surgery
Study Arms (1)
Major abdominal surgery
Patients having major abdominal surgery
Interventions
All adult patients having major abdominal surgery
Eligibility Criteria
All adult patients having major abdominal surgery
You may qualify if:
- All adult patients undergoing major open elective gastrointestinal surgery lasting 3 hours or more will be eligible for the study.
You may not qualify if:
- Patients who are:
- undergoing emergency surgery
- suffering from chronic illness, (e.g. diabetes) or other debilitating diseases
- on long term anti-inflammatory drugs, (e.g. NSAIDS, Steroids, immunosuppressant)
- on long term antibiotics
- on statins
- on full therapeutic dose of anticoagulants, or aspirin \> 325 mg/day, clopidogrel \> 75 mg/day
- suffering from bleeding diathesis
- unable to give consent
- pregnant or breastfeeding
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
University Hospitals Nottingham Queen's Medical Centre
Nottingham, Nottingham, NG7 2UH, United Kingdom
Related Publications (2)
Atkins R, Constantin-Teodosiu D, Varadhan KK, Constantin D, Lobo DN, Greenhaff PL. Major elective abdominal surgery acutely impairs lower limb muscle pyruvate dehydrogenase complex activity and mitochondrial function. Clin Nutr. 2021 Mar;40(3):1046-1051. doi: 10.1016/j.clnu.2020.07.006. Epub 2020 Jul 14.
PMID: 32711950DERIVEDVaradhan KK, Constantin-Teodosiu D, Constantin D, Greenhaff PL, Lobo DN. Inflammation-mediated muscle metabolic dysregulation local and remote to the site of major abdominal surgery. Clin Nutr. 2018 Dec;37(6 Pt A):2178-2185. doi: 10.1016/j.clnu.2017.10.020. Epub 2017 Nov 2.
PMID: 29129636DERIVED
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- STUDY CHAIR
Dileep N Lobo, Professor
University of Notitngham
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
May 28, 2010
First Posted
June 2, 2010
Study Start
May 1, 2010
Primary Completion
May 1, 2013
Study Completion
May 1, 2013
Last Updated
June 9, 2015
Record last verified: 2015-06